InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Lyell Immunopharma, Inc.

LYEL Clue Score29
United States Fiscal year ends December CIK 0001806952
$8.71 -0.91% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.71 −28.61% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Jun 2021. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue0.7Operating income−102.1Net income−129.4EPS, diluted−24.04Fiscal year 2020Revenue7.8 +1,080.5%Operating income−211.9Net income−204.5EPS, diluted−15.69Fiscal year 2021Revenue10.7 +37.3%Operating income−214.8Net income−250.2EPS, diluted−1.84Fiscal year 2022Revenue84.7 +695.1%Operating income−187.1Net income−183.1EPS, diluted−0.74Fiscal year 2023Revenue0.1 −99.8%Operating income−247.0Net income−234.6EPS, diluted−18.70Fiscal year 2024Revenue0.1 −53.1%Operating income−358.8Net income−343.0EPS, diluted−26.23Fiscal year 2025Revenue0.0 −41.0%Operating income−269.4Net income−274.4EPS, diluted−16.06
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.7 7.8 10.7 84.7 0.1 0.1 0.0
Growth +1,080.5% +37.3% +695.1% −99.8% −53.1% −41.0%
Operating income −102.1 −211.9 −214.8 −187.1 −247.0 −358.8 −269.4
Net income −129.4 −204.5 −250.2 −183.1 −234.6 −343.0 −274.4
Growth
EPS, diluted −24.04 −15.69 −1.84 −0.74 −18.70 −26.23 −16.06

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−15,538.7%Net margin−19,692.1%Free cash flow margin3,565.8%Fiscal year 2020Operating margin−2,732.6%Net margin−2,636.3%Free cash flow margin−2,737.9%Fiscal year 2021Operating margin−2,016.7%Net margin−2,349.5%Free cash flow margin−1,800.5%Fiscal year 2022Operating margin−220.9%Net margin−216.2%Free cash flow margin−228.9%Fiscal year 2023Operating margin−190,006.2%Net margin−180,486.2%Free cash flow margin−127,984.6%Fiscal year 2024Operating margin−588,123.0%Net margin−562,285.2%Free cash flow margin−266,980.3%Fiscal year 2025Operating margin−748,344.4%Net margin−762,355.6%Free cash flow margin−418,900.0%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −15,538.7% −2,732.6% −2,016.7% −220.9% −190,006.2% −588,123.0% −748,344.4%
Net margin −19,692.1% −2,636.3% −2,349.5% −216.2% −180,486.2% −562,285.2% −762,355.6%
Free cash flow margin 3,565.8% −2,737.9% −1,800.5% −228.9% −127,984.6% −266,980.3% −418,900.0%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow39.5Capital expenditure−16.0Free cash flow23.4Buybacks−0.2Fiscal year 2020Operating cash flow−160.9Capital expenditure−51.5Free cash flow−212.4 −1,006.5%Buybacks−11.8Fiscal year 2021Operating cash flow−126.2Capital expenditure−65.5Free cash flow−191.8Buybacks0.0Fiscal year 2022Operating cash flow−169.6Capital expenditure−24.3Free cash flow−193.8Buybacks0.0Fiscal year 2023Operating cash flow−163.7Capital expenditure−2.7Free cash flow−166.4Fiscal year 2024Operating cash flow−162.4Capital expenditure−0.5Free cash flow−162.9Fiscal year 2025Operating cash flow−150.0Capital expenditure−0.8Free cash flow−150.8
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 39.5 −160.9 −126.2 −169.6 −163.7 −162.4 −150.0
Capital expenditure −16.0 −51.5 −65.5 −24.3 −2.7 −0.5 −0.8
Free cash flow 23.4 −212.4 −191.8 −193.8 −166.4 −162.9 −150.8
Growth −1,006.5%
Buybacks −0.2 −11.8 0.0 0.0 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash96.7Shareholders’ equity−111.1Fiscal year 2020Cash140.4Shareholders’ equity−292.5Fiscal year 2021Cash293.8Shareholders’ equity929.8Fiscal year 2022Cash123.6Shareholders’ equity833.3Fiscal year 2023Cash145.6Shareholders’ equity655.0Fiscal year 2024Cash105.6Shareholders’ equity382.8Fiscal year 2025Cash60.2Shareholders’ equity248.2
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 96.7 140.4 293.8 123.6 145.6 105.6 60.2
Shareholders’ equity −111.1 −292.5 929.8 833.3 655.0 382.8 248.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.7 7.8 10.7 84.7 0.1 0.1 0.0
Growth +1,080.5% +37.3% +695.1% −99.8% −53.1% −41.0%
63.6 182.2 138.7 159.2 182.9 n/a n/a
39.2 46.9 89.1 117.3 67.0 52.0 45.1
−102.1 −211.9 −214.8 −187.1 −247.0 −358.8 −269.4
Growth
n/a n/a n/a n/a n/a n/a 0.0
−129.4 −204.5 −250.2 −183.1 −234.6 −343.0 −274.4
Growth
Per share
−24.04 −15.69 −1.84 −0.74 −18.70 −26.23 −16.06
−24.04 −15.69 −1.84 −0.74 −18.70 −26.23 −16.06
Growth
0.0 13.3 135.9 247.1 12.5 13.1 17.1
0.0 13.3 135.9 247.1 12.5 13.1 17.1
Growth +244,107.0% +925.2% +81.8% −94.9% +4.2% +30.7%

† The diluted share count jumps at 2020 and 2021 and 2022 and 2023, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 65.9% a year over five years.
  • Operating margin is down 745,611.9 points on five years ago, at -748,344.4%.
  • A net loss in 7 of 7 years on file.